C
GILD icon

Certuity’s Gilead Sciences GILD Stock Holding History

Certuity’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$923K Sell
7,309
-690
-9% -$90.9K 0.05% 188
2026
Q1 		$1.11M Sell
7,999
-32
-0.4% -$4.48K 0.07% 152
2025
Q4 		$986K Sell
8,031
-65
-0.8% -$7.9K 0.06% 169
2025
Q3 		$899K Buy
8,096
+43
+0.5% +$4.89K 0.06% 170
2025
Q2 		$893K Sell
8,053
-2,029
-20% -$216K 0.08% 132
2025
Q1 		$1.13M Buy
10,082
+1,687
+20% +$174K 0.12% 113
2024
Q4 		$775K Buy
8,395
+2,574
+44% +$232K 0.08% 133
2024
Q3 		$488K Buy
5,821
+83
+1% +$6.33K 0.05% 185
2024
Q2 		$394K Buy
5,738
+2,440
+74% +$163K 0.03% 212
2024
Q1 		$242K Sell
3,298
-4,295
-57% -$330K 0.02% 277
2023
Q4 		$615K Buy
7,593
+4,431
+140% +$345K 0.06% 159
2023
Q3 		$237K Sell
3,162
-229
-7% -$17.6K 0.03% 225
2023
Q2 		$261K Sell
3,391
-81
-2% -$6.46K 0.03% 220
2023
Q1 		$288K Sell
3,472
-540
-13% -$44.7K 0.04% 167
2022
Q4 		$344K Sell
4,012
-6,862
-63% -$543K 0.05% 139
2022
Q3 		$671K Buy
10,874
+7,497
+222% +$473K 0.16% 69
2022
Q2 		$209K Sell
3,377
-1,784
-35% -$110K 0.05% 198
2022
Q1 		$307K Buy
5,161
+1,308
+34% +$83.6K 0.07% 204
2021
Q4 		$280K Sell
3,853
-1,773
-32% -$122K 0.06% 225
2021
Q3 		$393K Buy
5,626
+1,819
+48% +$128K 0.08% 206
2021
Q2 		$262K Sell
3,807
-719
-16% -$48K 0.06% 256
2021
Q1 		$293K Buy
4,526
+280
+7% +$18.1K 0.08% 209
2020
Q4 		$247K Sell
4,246
-248
-6% -$15K 0.08% 181
2020
Q3 		$284K Sell
4,494
-1,884
-30% -$131K 0.11% 132
2020
Q2 		$491K Sell
6,378
-895
-12% -$68.6K 0.23% 71
2020
Q1 		$552K Sell
7,273
-427
-6% -$29.5K 0.31% 56
2019
Q4 		$500K Buy
+7,700
New +$501K 0.24% 74

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Certuity's GILD Position: Q2 2026 in Review

Certuity reduced its Gilead Sciences (GILD) stake by 8.6% in Q2 2026, selling an estimated $90.9K and leaving 7,309 shares worth $923K. The position accounts for 0.05% of the portfolio, ranked #188.

Certuity first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.13M in Q1 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Certuity held 7,309 shares of Gilead Sciences worth $923K as of Q2 2026.
  • Certuity sold 690 Gilead Sciences shares in Q2 2026, an estimated $90.9K.
  • Gilead Sciences made up 0.05% of Certuity's portfolio in Q2 2026, its #188 holding.
  • Certuity first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • Certuity's Gilead Sciences position peaked at $1.13M in Q1 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.